Recent patterns and predictors of antipsychotic medication regimens used to treat schizophrenia and other psychotic disorders.
about
Antipsychotic combinations for schizophreniaMulti-Agent-Based Simulation of a Complex Ecosystem of Mental Health Care.Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapineA translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacyTreatment-refractory schizophrenia.Patterns of initiation of second generation antipsychotics for bipolar disorder: a month-by-month analysis of provider behavior.Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort studyCultural aspects of psychosis in the elderly.Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents.An audit of outpatient antipsychotic usage in the three health sectors of Auckland, New Zealand.Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a South Indian population.Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009.Antipsychotics prescribing patterns of patients with schizophrenia admitted to korean general hospital psychiatric unit: 2001 to 2008.Ethnicity and psychopharmacology.Choice of randomization to clozapine versus other second generation antipsychotics in the CATIE schizophrenia trialAntipsychotic polypharmacy: a Japanese survey of prescribers' attitudes and rationales.Bridging bench and practice: translational research for schizophrenia and other psychotic disorders.Explicit versus implicit review to explore combination antipsychotic prescribing.Communities of color? Client-to-client racial concordance in the selection of mental health programs for Caucasians and African Americans.Persistence of racial disparities in prescription of first-generation antipsychotics in the USA.Antipsychotic Use Pattern in People with Psychotic Disorder Living in Board and Care Facilities.Prescription patterns for patients with schizophrenia in Korea: a focus on antipsychotic polypharmacy.Off-label use of second generation antipsychotics for post-traumatic stress disorder in the Department of Veterans Affairs: time trends and sociodemographic, comorbidity, and regional correlates.Antipsychotic use in Australia: the patients' perspective.The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment.[Prevalence and characteristics of neuroleptic association in a patient cohort with psychotic disorders].Ethnic comparisons of antipsychotic use in schizophrenia.[Augmenting atypical antipsychotic medications with clozapin].The effect of income and race on quality of psychiatric care in community mental health centers.Distance matters in choice of mental health program: policy implications for reducing racial disparities in public mental health care.
P2860
Q24234513-9BD7AAD3-8AA5-445C-B0DC-1F395EC7B56BQ27315218-6689427A-470A-4437-8E67-0F82B16DB0D1Q28280783-92B00ABF-494F-4311-A655-CEF3C413D3F4Q30485065-0DFBE6F3-FF54-488B-9747-DAAE9D995F49Q34370955-7DC7FDBC-171E-4772-B456-9EABD649AA89Q34636572-1AC5BEC1-FFAB-4A06-BD4A-7D194BCDA058Q35030003-515217FA-2C93-407F-BCC2-BB19EF173A9BQ35599476-918F39F5-8285-4A5A-AFFA-8B7F835C8A9FQ35700356-E87ED251-27D9-4A9C-BA3A-0F23BDC5EC47Q35707526-FD28ECB6-365D-4197-AC1E-3221C3AE1B6CQ35939972-37F6A38F-4E00-423D-8F1A-46476F9837A0Q36057820-0E46B6B8-93BA-4433-9A9E-FB575C49BB07Q36599207-3C46C6C4-6BA3-46C1-B640-BE41A723BE74Q37097622-093EE09D-2FF1-462B-8CED-FB5F1CFD4073Q37212118-F190635E-EBBF-4301-A89F-35921A5D3E84Q37216848-0F211151-B94A-42A0-9F98-3770D3DF6A84Q37284670-8EB4F571-4E67-40A0-B647-942495B0801AQ37578712-DDB0C155-E998-45A0-800B-C1AB07937E40Q39984403-6E4544CE-14C8-4800-A4F6-BC6558B0174FQ40778551-96A93DF4-C59B-44FA-8D50-5F3C9C205DB3Q42180852-FE888568-0BA5-4BD1-BE85-45E54247E223Q42860052-04C62A51-10FE-4AD3-B231-6748BD77BF9EQ43413416-FFB983B5-3E1C-4052-98E4-8E25307E52C0Q44133345-1F7A185F-D18E-464A-ABA2-AECB9FC12893Q44311423-44463A62-9D3B-4138-975D-E4C71CD65D57Q45143157-3267833A-07A9-4C51-8259-1BE0FFF8E0EFQ46382373-6FC55175-4A03-409F-BE94-615DA36520CAQ46396387-F261580D-7BCC-4F08-BF31-8F768B6DD4B1Q46538504-945AE211-1009-411C-B8A2-39DF1AA4E01AQ46563755-E6A038C2-D12D-433D-9D93-FFC77BA7C69B
P2860
Recent patterns and predictors of antipsychotic medication regimens used to treat schizophrenia and other psychotic disorders.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Recent patterns and predictors ...... and other psychotic disorders.
@en
Recent patterns and predictors ...... and other psychotic disorders.
@nl
type
label
Recent patterns and predictors ...... and other psychotic disorders.
@en
Recent patterns and predictors ...... and other psychotic disorders.
@nl
prefLabel
Recent patterns and predictors ...... and other psychotic disorders.
@en
Recent patterns and predictors ...... and other psychotic disorders.
@nl
P2093
P1476
Recent patterns and predictors ...... and other psychotic disorders.
@en
P2093
P304
P356
10.1093/OXFORDJOURNALS.SCHBUL.A033465
P407
P577
2000-01-01T00:00:00Z